With this new batch with doses of the Pfizer covid-19 vaccine that arrives in Panama, the Minsa will reinforce the vaccination process in the country.
After a delay of more than 24 hours, Panama received this Wednesday, May 19, the fifteenth batch of
vaccines against
COVID-19 of the formula developed by the pharmaceutical company
Pfizer and
BioNTech, with 108,810 new doses.
With this new group of doses, the Ministry of Health (
Minsa) will reinforce the vaccination process at the national level, with which, the million
vaccines that the pharmaceutical company
Pfizer has sent to Panama since last January 20, 2021 are exceeded.
Breakdown of deliveries made by
Pfizer to Panama:
January 20: 12,840 doses
February 17: 67,860 doses
February 24: 77,220 doses
March 3: 87,550 doses
March 10: 42,210 doses
March 16: 63,180 doses
March 24: 70,200 doses
March 30: 36,270 doses
April 5: 77,220 doses
April 14: 77,220 doses
April 20: 77,220 doses
April 27: 78,390 doses
May 4: 70,200 doses
May 11: 70,200 doses
May 19: 108,810
With the arrival of the
Pfizer shipment this Wednesday, people who had to be vaccinated yesterday, May 18, at Vasco Núñez de Balboa, will have to reschedule their
vaccine, as reported by the Deputy Minister of Health, Ivette Berrío.
This, after the pharmaceutical company
Pfizer indicated on Tuesday, that it presented problems in the shipment.
It is scheduled that the batch should reinforce the application of the
vaccine in adults over 60 years of age, pregnant women and teachers in the 9-1 circuit in the province of Veraguas, and circuits 4-3 and 4-4 in the province of Chiriquí .
In addition, this batch will allow to cover the second doses in circuits 8-4 (Balboa, Chepo, Chimán and Taboga) and 8-7 (Ancón, Bella Vista, Betania, Calidonia, Curundú, El Chorrillo, Pueblo Nuevo, San Felipe, and Saint Ana).
In Panama, 849, 376 doses of the
vaccine against
COVID-19 have been applied, from January 20 to date, this according to data from the Expanded Program on Immunization (PAI).
Currently, in Panama doses of
vaccines against
covid-19 developed by
Pfizer and
AstraZeneca are being applied.